Grading of follicular lymphoma: Comparison of routine histology with immunohistochemistry

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 7, 2007, Pages 1084-1088

  Martinez, Antonio E ^a,c   Lin, Li ^b   Dunphy, Cherie H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CD3 ANTIGEN; CD30 ANTIGEN; CD68 ANTIGEN; KI 67 ANTIGEN; PROTEIN BCL 6; TRANSCRIPTION FACTOR PAX5;

ANTIBODY DETECTION; ARTICLE; CANCER GRADING; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDY;

ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD30; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; B-CELL-SPECIFIC ACTIVATOR PROTEIN; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOMA, FOLLICULAR;

EID: 34447331977     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer. 1997;80:2311-2320.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours; vol 3.
3. Mann RB, Berard CW. Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method. Hematol Oncol. 1983;1:187-192.
4. Nathwani BN, Metter GE, Miller TP, et al. What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood. 1986;4:837-845.
5. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
6. Glas AM, Kersten J, Delahaye LJMJ, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood. 2005;105:301-307.
7. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159-2169.
8. Muller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:1-12.
9. Mourad WA, Rawas F, Shoukri M, et al. Grading follicular lymphoma by using flow cytometry. Ann Saudi Med. 2006;26:205-210.
10. Macartney JC, Camplejohn RS, Morris R, et al. DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol. 1991;44:215-218.
11. Dunphy CH. Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology. Arch Pathol Lab Med. 2004;128:1004-1022.
12. Bilalovic N, Blystad KB, Golouh R, et al. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol. 2004;121:34-42.
13. Torlakovic EE, Bilalovic N, Golouh R, et al. Prognostic significance of PU.1 in follicular lymphoma. J Pathol. 2006;209:352-359.
14. Martin AR, Wesenburger DD, Chan WC, et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood. 1995;85:3671-3678.
15. Wang SA, Wang L, Hochberg EP, et al. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol. 2005;29:1490-1496.
16. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.